Groundbreaking cell and gene therapy manufacturing and commercialization

We’ve been manufacturing cutting edge cell and gene therapies for over 20 years

cell therapies is an Australian-based, globally-active commercial contract development and manufacturing company, specializing in cell therapy, gene therapy, regenerative medicine, and cellular immunotherapy products.

A leader in this groundbreaking field, our expert team and world-class facilities have been developing and manufacturing cutting edge treatments for cancer and rare diseases on behalf of local and international clients since 2003.

Explore our services

Cell Therapies has extensive experience in the development and commercialization of cell and gene therapies for the Australian and global markets.

Apheresis Management

Over 18 years’ experience managing apheresis collections under GMP quality oversight

Contract Manufacturing

Licensed GMP manufacturing and process development for clinical trials and commercial supply

Clinical Trial Support

Enabling global clinical trial establishment by assisting from trial design to regulatory submission

Consulting and Advisory

The expertise to advance your program from clinical trial through to commercial supply

Industry-leading GMP facility delivering cell and gene therapies from Australia to the world

cell therapies GMP facility is located in Melbourne, Australia, and has manufacturing licences for clinical and commercial supply from Australia’s regulatory agency, the Therapeutic Goods Administration (TGA). Our facility also complies with global regulatory standards for US (FDA), Europe (EMA), Japan (MHLW) and other jurisdictions.

Our Partners and Affiliations

Latest News

Cell Therapies to manufacture BioNTech’s product candidate BNT211 in Australia

| News | No Comments
Cell Therapies Pty Ltd (CTPL) has been engaged by Germany-based biopharmaceutical company BioNTech SE (BioNTech) to manufacture BioNTech’s novel CAR-T cell therapy candidate BNT211 in Australia. The candidate is an…

Cell Therapies Joins Australia’s Cell & Gene Catalyst Steering Group

| News | No Comments
We are delighted to be part of the Steering Group to lead Australia’s Cell and Gene Catalyst. The Steering Group comprises AusBiotech, Medicines Australia, CSL Behring, Pfizer, Novartis, Therapeutic Innovation Australia, and Cell Therapies. The…

Carina Biotech partners with Cell Therapies to deliver a first-in-human CAR-T cell therapy trial to treat colorectal patients

| News | No Comments
Cell Therapies is partnering with Carina Biotech, a leading Australian immuno-oncology company, to manufacture their CAR-T cell therapy for patients with colorectal cancer. Colorectal cancer is the deadliest cancer for…
Victorian State Government

Former Cell Therapies’ Chair appointed as Victoria’s New Lieutenant-Governor

| News | No Comments
Professor James Angus has been appointed the new Lieutenant-Governor of Victoria by Her Excellency the Honourable Linda Dessau AC, Governor of Victoria. Professor Angus has had a long and distinguished…

Contact the Cell Therapies Team today

Reach out to our expert team by entering your details below and we will get into contact with you.